The agreement gives Pharmanovia the exclusive rights to bring to market, catumaxomab, a first-in-class, trifunctional bi-specific monoclonal antibody, indicated for the intraperitoneal treatment of ...
In the run-up to World AIDS Day Steven Haberman, Professor of Actuarial Science at Bayes Business School, City St George's University of London Steven Haberman made in the 1980s to assessing the ...